未登录 Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study Preda, Alexandra C.; Krasteva, Rossitza; Stjepanovic, Mihailo; Koynov, Krassimir; Konsoulova, Assia; Iorga, Georgeta P.; Udrea, Anghel A.; Zgura, Anca; Ciuleanui, Tudor-Eliade; Arabadjiev, Raluca Patruj Jeliazko; Tonev, Ivan; Andric, Zoran; Stojanovic, Goran; Pasca-Fenesan, Mihaela; Pirvu, Edvina-Elena; Iliev, Bojidar; Kazmukov, Ivan; Petrov, Angel; Nikolic, Neda; Mushmova, Marina; Simic, Ivana; Georgescu, Oana R.; Schenker, Michael 分享 收藏
分享 收藏
分享 收藏
Prospective Upfront Next-Generation Sequencing for Advanced Non-Small Cell Lung Cancer: Real-World Outcomes from the Ion Chiricuta Oncology Institute 前瞻性早期下一代测序在晚期非小细胞肺癌中的应用：Ion Chiricuta肿瘤研究所的真实世界结果 Preda, Alexandra Cristina; Todor, Nicolae; Carlan, Bogdan; Kubelac-Varro, Adelina-Dadiana; Iancu, Dana Ioana; Mocan, Cristina; Vasilica, Mariana Bandi; Kubelac, Milan-Paul; Vlad, Catalin; Ciuleanu, Tudor Eliade 分享 收藏
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial 在CheckMate 9LA随机试验中，转移性非小细胞肺癌患者一线nivolumab联合ipilimumab进行2周期化疗与单独4周期化疗的五年结果 Reck, Martin; Ciuleanu, Tudor-Eliade; Schenker, Michael; Bordenave, Stephanie; Cobo, Manuel; Juan-Vidal, Oscar; Reinmuth, Niels; Richardet, Eduardo; Felip, Enriqueta; Menezes, Juliana; Cheng, Ying; Mizutani, Hideaki; Zurawski, Bogdan; Alexandru, Aurelia; Carbone, David P.; Lu, Shun; John, Thomas; Aoyama, Takekazu; Grootendorst, Diederik J.; Hu, Nan; Eccles, Laura J.; Paz-Ares, Luis G. 分享 收藏
6y update of 1L nivolumab plus ipilimumab (N plus I) in metastatic (m) NSCLC, including in Japanese pts, from CheckMate 227 Nishio, M.; Ramalingam, S. S.; Ciuleanu, T.; Caro, R. Bernabe; Mizutani, H.; Lee, J.; Audigier-Valette, C.; Sangha, R.; Urban, L.; Burgers, J. A.; Pluzanski, A.; Lee, K. Hyeong; Zurawski, B.; Schenker, M.; Peters, S.; Paz-Ares, L. G.; Borghaei, H.; O'Byrne, K. J.; Brahmer, J. R.; Gupta, R. G.; Bushong, J.; Li, L.; Yuan, Y.; Blum, S. I.; Reck, M. 分享 收藏
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC Sotorasib (960 mg或240 mg) 每天一次用于先前接受过KRAS治疗的晚期NSCLC患者G12C-mutated Hochmair, Maximilian J.; Vermaelen, Karim; Mountzios, Giannis; Carcereny, Enric; Dooms, Christophe; Lee, Se-Hoon; Morocz, Eva; Kato, Terufumi; Ciuleanu, Tudor-Eliade; Dy, Grace K.; Parente, Barbara; O'Byrne, Kenneth J.; Chu, Quincy S.; De Castro Junior, Gilberto; Girard, Nicolas; Snyder, Wendy; Tran, Qui; Kormany, William; Houk, Brett; Mehta, Bhakti; Curioni-Fontecedro, Alessandra 分享 收藏
Perioperative Nivolumab in Resectable Lung Cancer 可切除肺癌的围手术期Nivolumab Cascone, Tina; Awad, Mark M.; Spicer, Jonathan D.; He, Jie; Lu, Shun; Sepesi, Boris; Tanaka, Fumihiro; Taube, Janis M.; Cornelissen, Robin; Havel, Libor; Karaseva, Nina; Kuzdzal, Jaroslaw; Petruzelka, Lubos B.; Wu, Lin; Pujol, Jean-Louis; Ito, Hiroyuki; Ciuleanu, Tudor-Eliade; Muniz Koch, Ludmila de Oliveira; Janssens, Annelies; Alexandru, Aurelia; Bohnet, Sabine; Moiseyenko, Fedor V.; Gao, Yang; Watanabe, Yasutaka; Erdmann, Cinthya Coronado; Sathyanarayana, Padma; Meadows-Shropshire, Stephanie; Blum, Steven I.; Provencio Pulla, Mariano 分享 收藏
Telisotuzumab vedotin monotherapy in Asian patients with c-Meteoverexpressing advanced non-small cell lung cancer Horinouchi, Hidehito; Camidge, D. Ross; Bar, Jair; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Bradbury, Penelope; Daaboul, Nathalie; Tomasini, Pascale; Ciuleanu, Tudor; Planchard, David; Moskovitz, Mor; Girard, Nicolas; Dunbar, Martin; Bolotin, Ellen; Looman, Jim; Ratajczak, Christine; Lu, Shun 分享 收藏
Xevinapant plus avelumab in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Phase 1b dose-expansion results and exploratory biomarker analyses Chu, Quincy; Ciuleanu, Tudor; Ramlau, Rodryg; Renouf, Daniel; Juergens, Rosalyn; Kalinka, Ewa; Sawrycki, Piotr; Bramson, Jonathan; Nelson, Brad; Crabbe, Rafael; Sahlender, Daniela A.; Crompton, Philippa; Rouits, Elisabeth; Spaggiari, Dany; Brichory, Franck; Piggott, Luke; Schenker, Mike; Goss, Glenwood 分享 收藏
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes 一线nivolumab联合ipilimumab两周期化疗与单纯化疗 (四个周期) 治疗转移性非小细胞肺癌: CheckMate 9LA 2年患者报告的结果 Reck, Martin; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Cheng, Ying; Sakai, Hiroshi; Paz-Ares, Luis; Lu, Shun; John, Thomas; Sun, Xiaowu; Moisei, Aniela; Taylor, Fiona; Lawrance, Rachael; Zhang, Xiaoqing; Sylvester, Judi; Yuan, Yong; Blum, Steven I.; Penrod, John R.; Carbone, David P. 分享 收藏
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer Forde, Patrick M.; Spicer, Jonathan; Lu, Shun; Provencio, Mariano; Mitsudomi, Tetsuya; Awad, Mark M.; Felip, Enriqueta; Broderick, Stephen R.; Brahmer, Julie R.; Swanson, Scott J.; Kerr, Keith; Wang, Changli; Ciuleanu, Tudor-Eliade; Saylors, Gene B.; Tanaka, Fumihiro; Ito, Hiroyuki; Chen, Ke Neng; Liberman, Moishe; Vokes, Everett E.; Taube, Janis M.; Dorange, Cecile; Cai, Junliang; Fiore, Joseph; Jarkowski, Anthony; Balli, David; Sausen, Mark; Pandya, Dimple; Calvet, Christophe Y.; Girard, Nicolas 分享 收藏
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817 一线nivolumab联合ipilimumab治疗转移性非小细胞肺癌，包括ECOG表现状态2和其他特殊人群的患者: CheckMate 817 Ready, Neal E.; Audigier-Valette, Clarisse; Goldman, Jonathan W.; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Campelo, Maria Rosario Garcia; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stephanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sebastien; Zannori, Cristina; Vermaelen, Karim; Frontera, Osvaldo Aren; Fontecedro, Alessandra Curioni; Sanchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R.; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis 分享 收藏
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis Borghaei, H.; Ciuleanu, T. -E.; Lee, J. -S; Pluzanski, A.; Caro, R. Bernabe; Gutierrez, M.; Ohe, Y.; Nishio, M.; Goldman, J.; Ready, N.; Spigel, D. R.; Ramalingam, S. S.; Paz-Ares, L. G.; Gainor, J. F.; Ahmed, S.; Reck, M.; Maio, M.; O'Byrne, K. J.; Memaj, A.; Nathan, F.; Tran, P.; Hellmann, M. D.; Brahmer, J. R. 分享 收藏
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial lurbinectedin和阿霉素联合化疗与医生选择的复发性小细胞肺癌患者 (ATLANTIS): 一项多中心，随机，开放标签的3期试验 Aix, Santiago Ponce; Ciuleanu, Tudor Eliade; Navarro, Alejandro; Cousin, Sophie; Bonanno, Laura; Smit, Egbert F.; Chiappori, Alberto; Olmedo, Maria Eugenia; Horvath, Ildiko; Grohe, Christian; Farago, Anna F.; Lopez-Vilarino, Jose Antonio; Cullell-Young, Martin; Nieto, Antonio; Vasco, Noelia; Gomez, Javier; Kahatt, Carmen; Zeaiter, Ali; Carcereny, Enric; Roubec, Jaromir; Syrigos, Konstantinos; Lo, Gregory; Barneto, Isidoro; Pope, Anthony; Sanchez, Amparo; Kattan, Joseph; Zarogoulidis, Konstantinos; Waller, Cornelius F.; Bischoff, Helge; Juan-Vidal, Oscar; Reinmuth, Niels; Domine, Manuel; Paz-Ares, Luis 分享 收藏
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial Pal, Sumanta K.; Puente, Javier; Heng, Daniel Y. C.; Glen, Hilary; Koralewski, Piotr; Stroyakovskiy, Daniil; Alekseev, Boris; Parnis, Francis; Castellano, Daniel; Ciuleanu, Tudor; Lee, Jae Lyun; Sunela, Kaisa; O'Hara, Karen; Binder, Terri A.; Peng, Lixian; Smith, Alan D.; Rha, Sun Young 分享 收藏
Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuta Oncology Institute series Preda, A.; Ciuleanu, T.; Kubelac, P.; Todor, N.; Balacescu, O.; Achimas-Cadariu, P.; Iancu, D.; Mocan, C.; Bandi-Vasilica, M.; Lupse, M.; Briciu, V. T.; Man, M. A.; Vlad, C. 分享 收藏
Nivolumab (NIVO) plus ipilimumab (IPI) as first-line (1L) treatment (tx) for patients (pts) with advanced NSCLC (aNSCLC) and baseline (BL) brain metastases (mets): Intracranial and systemic outcomes from CheckMate 227 Part 1 Reck, M.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Caro, R. Bernabe; Linardou, H.; Burgers, J.; Gallardo, C.; Nishio, M.; Peters, S.; Paz-Ares, L. G.; Hellmann, M. D.; Borghaei, H.; Ramalingam, S. S.; O'Byrne, K.; Hu, N.; Bushong, J.; Eccles, L.; Grootendorst, D.; Brahmer, J. R. 分享 收藏
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT) Addeo, Alfredo; Hochmair, Maximilian; Janzic, Urska; Dudnik, Elizabeth; Charpidou, Andriani; Pluzannski, Adam; Ciuleanu, Tudor; Donev, Ivan Shterev; Elbaz, Judith; Aaroe, Jorgen; Ott, Rene; Peled, Nir 分享 收藏
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update 一线nivolumab联合ipilimumab两周期化疗与单纯化疗 (四个周期) 治疗晚期非小细胞肺癌: CheckMate 9LA 2年更新 Reck, M.; Ciuleanu, T. -E.; Cobo, M.; Schenker, M.; Zurawski, B.; Menezes, J.; Richardet, E.; Bennouna, J.; Felip, E.; Juan-Vidal, O.; Alexandru, A.; Sakai, H.; Lingua, A.; Reyes, F.; Souquet, P. -J.; De Marchiy, P.; Martin, C.; Perol, M.; Scherpereel, A.; Lu, S.; Paz-Ares, L.; Carbone, D. P.; Memaj, A.; Marimuthu, S.; Zhang, X.; Tran, P.; John, T. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏
OAAI